# A Clinical Study of HRS-8364 in the Treatment of Advanced Solid Tumor Subjects

> **NCT07446153** · PHASE1,PHASE2 · RECRUITING · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 282 (estimated)

## Conditions studied

- Solid Tumor

## Interventions

- **DRUG:** HRS-8364 Tablet

## Key facts

- **NCT ID:** NCT07446153
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-19
- **Primary completion:** 2028-12
- **Final completion:** 2029-12
- **Target enrollment:** 282 (ESTIMATED)
- **Last updated:** 2026-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07446153

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07446153, "A Clinical Study of HRS-8364 in the Treatment of Advanced Solid Tumor Subjects". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07446153. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*